These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25817046)

  • 61. Complete remission of extensive cutaneous metastatic melanoma on the scalp under topical mono-immunotherapy with diphenylcyclopropenone.
    Hinz T; Ehler LK; Bieber T; Schmid-Wendtner MH
    Eur J Dermatol; 2013; 23(4):532-3. PubMed ID: 24002471
    [No Abstract]   [Full Text] [Related]  

  • 62. Antiangiogenic treatment in metastatic urothelial cancer.
    Galsky MD
    Lancet Oncol; 2012 Aug; 13(8):748-9. PubMed ID: 22819171
    [No Abstract]   [Full Text] [Related]  

  • 63. Glycosaminoglycan and versican deposits in taxane-induced sclerosis.
    Okada K; Endo Y; Miyachi Y; Koike Y; Kuwatsuka Y; Utani A
    Br J Dermatol; 2015 Oct; 173(4):1054-8. PubMed ID: 25973640
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Response of refractory Ewing sarcoma to pazopanib.
    Alcindor T
    Acta Oncol; 2015 Jul; 54(7):1063-4. PubMed ID: 25345493
    [No Abstract]   [Full Text] [Related]  

  • 65. Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trial.
    Necchi A; Mariani L; Zaffaroni N; Schwartz LH; Giannatempo P; Crippa F; Morosi C; Lanocita R; Sava T; Ortega C; Messina C; Sacco C; Pennati M; Daidone MG; Nicolai N; De Braud F; Gianni AM; Salvioni R
    Lancet Oncol; 2012 Aug; 13(8):810-6. PubMed ID: 22819172
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pazopanib a tyrosine kinase inhibitor with strong anti-angiogenetic activity: a new treatment for metastatic soft tissue sarcoma.
    Ranieri G; Mammì M; Donato Di Paola E; Russo E; Gallelli L; Citraro R; Gadaleta CD; Marech I; Ammendola M; De Sarro G
    Crit Rev Oncol Hematol; 2014 Feb; 89(2):322-9. PubMed ID: 24041629
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Targeted therapy of dermatofibrosarcoma with imatinib].
    Ugurel S
    J Dtsch Dermatol Ges; 2007 Mar; 5(3):261. PubMed ID: 17338806
    [No Abstract]   [Full Text] [Related]  

  • 68. Complete pathologic response in soft tissue sarcoma lung metastases with pazopanib.
    Eroglu Z; Kim J; Wilczynski S; Chow WA
    J Thorac Oncol; 2014 Jan; 9(1):e4-6. PubMed ID: 24346105
    [No Abstract]   [Full Text] [Related]  

  • 69. Ring a ring o'roses, a patient with Kaposi's? Pazopanib, pazopanib, it might go away. Mediterranean (classic) Kaposi sarcoma responds to the tyrosine kinase inhibitor pazopanib after multiple lines of standard therapy.
    Harris BHL; Walsh JL; Neciunaite R; Manders P; Cooper A; De Souza P
    Clin Exp Dermatol; 2018 Mar; 43(2):234-236. PubMed ID: 29282751
    [No Abstract]   [Full Text] [Related]  

  • 70. Pazopanib for second recurrence of osteosarcoma in pediatric patients.
    Umeda K; Kato I; Saida S; Okamoto T; Adachi S
    Pediatr Int; 2017 Aug; 59(8):937-938. PubMed ID: 28685501
    [No Abstract]   [Full Text] [Related]  

  • 71. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face.
    Fata F; O'Reilly E; Ilson D; Pfister D; Leffel D; Kelsen DP; Schwartz GK; Casper ES
    Cancer; 1999 Nov; 86(10):2034-7. PubMed ID: 10570428
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Complete resolution of angiosarcoma of the scalp with liposomal daunorubicin and radiotherapy.
    Lankester KJ; Brown RS; Spittle MF
    Clin Oncol (R Coll Radiol); 1999; 11(3):208-10. PubMed ID: 10465481
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Exceptional Response to Pazopanib in a Patient with Urothelial Carcinoma Harboring FGFR3 Activating Mutation and Amplification.
    Palma N; Morris JC; Ali SM; Ross JS; Pal SK
    Eur Urol; 2015 Jul; 68(1):168-70. PubMed ID: 25766722
    [No Abstract]   [Full Text] [Related]  

  • 74. [Tyrosine kinase inhibitors in tumor therapy--part 2. Current position and perspectives].
    Grimm CF; Blum HE; Geissler M
    Dtsch Med Wochenschr; 2005 Jun; 130(23):1438-42. PubMed ID: 15929020
    [No Abstract]   [Full Text] [Related]  

  • 75. Desmoplastic Small Round Cell Tumor of the Pleura Successfully Treated with a Lower Dose of Pazopanib.
    Ikeue T; Ohi I; Noguchi S; Fukao A; Terashita S; Horikawa S; Sugita T
    Intern Med; 2016; 55(17):2463-7. PubMed ID: 27580551
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Chromophobe renal cell carcinoma with sarcomatoid dedifferentiation treated with pazopanib: a case report.
    Matrana MR; Ng C; Rao P; Lim ZD; Tannir NM
    Clin Genitourin Cancer; 2011 Dec; 9(2):137-9. PubMed ID: 21831725
    [No Abstract]   [Full Text] [Related]  

  • 77. Anti-angiogenic effects of the receptor tyrosine kinase inhibitor, pazopanib, on choroidal neovascularization in rats.
    Yafai Y; Yang XM; Niemeyer M; Nishiwaki A; Lange J; Wiedemann P; King AG; Yasukawa T; Eichler W
    Eur J Pharmacol; 2011 Sep; 666(1-3):12-8. PubMed ID: 21620822
    [TBL] [Abstract][Full Text] [Related]  

  • 78. First sonographic description of idiopathic Cutaneous Angiosarcoma of the Head and Neck.
    Vilas Boas P; Ruedas Martínez A; Baniandrés Rodriguez O; Ciudad Blanco C
    Actas Dermosifiliogr; 2017 Dec; 108(10):960-962. PubMed ID: 28803613
    [No Abstract]   [Full Text] [Related]  

  • 79. [Pazopanib for treatment of renal cell carcinoma and soft tissue sarcomas].
    Brotelle T; Bay JO
    Bull Cancer; 2014 Jun; 101(6):641-6. PubMed ID: 24977453
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Enterocolitis: An Unknown Side Effect of Pazopanib.
    Sharma A; Masood U; Manocha D
    Am J Ther; 2017; 24(4):e490-e491. PubMed ID: 27574944
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.